|
The Department of Pharmaceuticals (DoP) under the ministry of chemicals and fertilizers, has announced the second edition of the India MedTech Expo 2025 to be held from September 4 to 6, in New Delhi.
The expo will be organised by the DoP in association with the ministry of commerce and industry, Export Promotion Council for Medical Devices (EPCMD), and Central Drugs Standard Control Organisation (CDSCO), as part of the larger Bharat Health 2025 initiative.
The three-day expo titled ‘India: Global MedTech manufacturing Hub, Precision Engineering yet Affordable’ will feature an expansive exhibition showcasing micro, small, and medium enterprises (MSMEs), start-ups, research institutions, future innovation pavilions, state showcases, and government initiatives, and bring together policymakers, global business leaders, innovators, investors, and healthcare stakeholders.
The conclave will include thematic conferences, CEO roundtables, fireside chats, and state-focused sessions, with the participation of Union and state ministers. Experience zones and networking opportunities such as B2B meetings, Reverse Buyer-Seller Meets, and regulator open houses will further enable collaborations across the med-tech value chain.
Jagat Prakash Nadda, Union minister for health & family welfare and chemicals and fertilizers and Jitin Prasada, Union minister of state for commerce & industry and electronics & IT will be inaugurating the event. Amit Agrawal, Secretary, DoP, ministry of chemicals and fertilizers, Nitin Kumar Yadav, additional secretary, Department of Commerce, P Krishnamurthy, chairman NPPA, Dr Rajeev Singh Raghuvanshi, Drug Controller General of India, and R P Singh, joint secretary, DoP, will be participating in the event.
Other key speakers include, Rakesh Kumar Singh, CEO, YEIDA, Medical Device Park, UP; Awadhesh Chaudhary, senior economic advisor, DoP, Pramod Meshram, Deputy Drugs Controller (India), CDSCO IVD Division, etc.
Speaking about the upcoming edition, Praveen Kumar Mittal, executive director, EPCMD, said, “India’s medical devices sector has grown to a market size of nearly USD 15 billion and is projected to reach USD 30 billion by 2030. With more than 800 MedTech start-ups, strong R&D capabilities, and a fast-growing manufacturing base, we are positioning India as not just a consumer market, but as a global innovation and export hub. India MedTech Expo 2025 will be the catalyst to showcase this growth story and enable collaborations that can transform healthcare access both in India and worldwide.”
The event will witness participation from over 150 international buyers representing more than 30 countries, offering a unique opportunity for global stakeholders to explore partnerships and investments in India’s rapidly expanding MedTech ecosystem.
Leading associations including AIMED, ADMI, MTAI, AMTZ, AMCHAM, APACMED, ADVAMED, APMEI, ASSOCHAM, CII, FICCI, INVEST INDIA, PHDCCI, NATHEALTH, USIBC, and USISPF are supporting the event and the expo will serve as a collective platform to shape the future of medical technology, said the organisers.
The Expo will feature various pavilions, including the Future Pavilion, R&D Pavilion, Start-up Pavilion, State Pavilion, Regulators’ Pavilion, and the Make in India Showcase.
More than 350 exhibitors, including MSMEs, domestic and international manufacturers, start-ups, regulatory agencies, and state governments, will participate in the 2nd edition, they added. The event will also feature thematic conference sessions to explore new frontiers of knowledge, inspire innovation, and forge connections that transcend boundaries. These sessions have been designed with the aim of achieving Vision 2047—a vision that embodies India’s aspirations for the MedTech sector, not only within the country but also as a significant contributor to the global healthcare landscape.
The Indian MedTech industry is currently the fourth-largest medical devices market in Asia, after Japan, China, and South Korea, and ranks among the top 20 medical devices markets globally. This industry is poised for significant growth, driven by the production linked incentive (PLI) scheme for medical devices and the establishment of four ‘Medical Device Parks’ across the country. The DoP is also formulating an India Medical Devices Policy, which is currently at the inter-ministerial consultation stage, it added.
|